… Several prognostic factors for recurrence and survival … platinum-based chemotherapy to
disease recurrence, is recognized as a major prognostic factor for patients with ovarian cancer [7,…

… The response to NACT is reported as one of the most vital prognostic factors for patients … ,
and the response was an independent prognostic predictor, with an hazard ratio (HR) of 6.963. …

… who underwent intensity-modulated radiotherapy (IMRT) with concurrent platinum-based
chemotherapy in Xiangya Hospital from January 2014 to June 2017. The clinicopathological …

… recurrence, yet at the expense of a varying degree of toxicity and morbidity. In the present
study, platinum-based chemotherapy … prognosis than squamous cell carcinoma in patients with …

… Other than that, platinum-based chemotherapy is the mainstay for these … for predicting PRS
in patients with recurrent cervical cancer, independent of other factors associated with PRS. …

… -line treatment with platinum-based chemotherapy and cetuximab in patients with
relapsing/metastatic head and neck cancer (RM HNC) and to identify predictors of treatment …

… The prognosis of patients with recurrent disease remains very poor, with an … a platinum-based
CT with or without bevacizumab as first-line treatment of persistent, recurrent, or metastatic …

… factors, including stage of disease, lymph node metastasis, … identify significant prognostic
factors that predict cancer specific … 71.8% of patients received a platinum-based agent (cisplatin …

… prognostic factors in patients harbouring locally advanced uterine cervical cancer treated
with … This study analysed prognostic factors for local recurrence, distant recurrence and OS in …

… To explore potential predictive factors, we also calculated the hazard ratio (HR) and the …
(A) All prognostic factors for OS are included in circle A and all prognostic factors for PFS …